Global Leader On Behavioural Science In Tobacco Harm Reduction And ENDS Regulation.
CSUR opened in 1994 linked initially to the University of Glasgow where its foundational director held the post of Professor of Substance Use Research. In 2011 CSUR became a wholly independent research centre focussing on a wider range of substance use issues and developing a large programme of behaviourally focussed regulatory science research assessing the impact of ENDS on tobacco related health harm. The team within CSUR comprises post-doctoral researchers in behavioural science, experts in marketing, cyber security, and media. The research team within CSUR have experience in working alongside regulatory authorities including FDA to ensure that the studies executed can meet the needs of regulatory and public health bodies. CSUR also has direct experience of working with some of the major global panel companies including IPSOS MORI Qualtrics to broaden the coverage of its studies. CSUR as an organization is focussed on furthering the goals of tobacco related harm reduction and assessing the public health impact of Electronic Nicotine Delivery Systems. The goal of CSUR’s staff is to ensure that those working within these industries have access to high quality behavioural research that can further their owns goals of reducing the harms associated with the use of combustible tobacco products.
Head of research
Head of Longitudinal Research
Head of Prevalence Research
Senior Research Fellow: Prevalence
Senior Qualitative Researcher
Within the U.S. CSUR legal representation is provided by Sheppard Mullin Richter and Hampton